Mirum Pharmaceuticals (MIRM) Interest & Investment Income (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Interest & Investment Income of $3.4 million for Q1 2026, up 12.5% year-over-year from $3.0 million in Q1 2025, and down 0.56% quarter-over-quarter from $3.4 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Interest & Investment Income (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $3.4 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 12.5% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $13.1 million (down 0.58% YoY), while the FY2025 annual figure was $12.7 million, down 7.72% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $3.4 million, down from $3.4 million in the prior quarter.
- The five-year high for Interest & Investment Income was $4.1 million in Q3 2023, with the low at $69000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $3.3 million (2025), against an average of $2.8 million.
- Peak annual rise in Interest & Investment Income reached 3196.92% in 2022, while the deepest fall reached 53.69% in 2022.
- Mirum Pharmaceuticals' Interest & Investment Income stood at $2.1 million in 2022, then surged by 76.15% to $3.8 million in 2023, then decreased by 15.13% to $3.2 million in 2024, then rose by 6.74% to $3.4 million in 2025, then declined by 0.56% to $3.4 million in 2026.
- Business Quant data shows MIRM's Interest & Investment Income at $3.4 million in Q1 2026, $3.4 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.85 Mn |
| Mar 31, 2026 | 3.40 Mn |
| Dec 31, 2025 | 3.42 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 3.63 Mn |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 4.06 Mn |
| Jun 30, 2023 | 3.63 Mn |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 293,000.00 |
| Mar 31, 2022 | 69,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Sep 30, 2021 | 72,000.00 |